Your browser doesn't support javascript.
loading
Intranasal Delivery of Oncolytic Adenovirus XVir-N-31 via Optimized Shuttle Cells Significantly Extends Survival of Glioblastoma-Bearing Mice.
El-Ayoubi, Ali; Klawitter, Moritz; Rüttinger, Jakob; Wellhäusser, Giulia; Holm, Per Sonne; Danielyan, Lusine; Naumann, Ulrike.
Afiliação
  • El-Ayoubi A; Molecular Neurooncology, Department of Vascular Neurology, Hertie Institute for Clinical Brain Research and Center Neurology, University of Tübingen, D-72076 Tübingen, Germany.
  • Klawitter M; Molecular Neurooncology, Department of Vascular Neurology, Hertie Institute for Clinical Brain Research and Center Neurology, University of Tübingen, D-72076 Tübingen, Germany.
  • Rüttinger J; Molecular Neurooncology, Department of Vascular Neurology, Hertie Institute for Clinical Brain Research and Center Neurology, University of Tübingen, D-72076 Tübingen, Germany.
  • Wellhäusser G; Molecular Neurooncology, Department of Vascular Neurology, Hertie Institute for Clinical Brain Research and Center Neurology, University of Tübingen, D-72076 Tübingen, Germany.
  • Holm PS; Department of Urology, Klinikum Rechts der Isar, Technical University of Munich, D-81675 Munich, Germany.
  • Danielyan L; Department of Oral and Maxillofacial Surgery, Medical University Innsbruck, A-6020 Innsbruck, Austria.
  • Naumann U; XVir Therapeutics GmbH, D-80331 Munich, Germany.
Cancers (Basel) ; 15(20)2023 Oct 10.
Article em En | MEDLINE | ID: mdl-37894279

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article